ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,612, issued on Aug. 12, was assigned to Intervet Inc. (Rahway, N.J.).
"Vaccine to protect a pig against Actinobacillus pleuropneumoniae" was invented by Maarten Hendrik Witvliet (Oostrum, Netherlands) and Johanna Jacoba Elisabeth Bijlsma (Nijmegen, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains to a vaccine to protect a pig against an infection with Actinobacillus pleuropneumoniae, the vaccine comprising an RTX toxin of Actinobacillus pleuropneumoniae recombinantly expressed by a baculovirus, and a pharmaceutically acceptable carrier."
The patent was filed on April 14, 2022, under Application No. 17/721,11...